DK1163271T3 - Rekombinant IL-18 antistoffer og deres anvendelse - Google Patents
Rekombinant IL-18 antistoffer og deres anvendelseInfo
- Publication number
- DK1163271T3 DK1163271T3 DK00918152T DK00918152T DK1163271T3 DK 1163271 T3 DK1163271 T3 DK 1163271T3 DK 00918152 T DK00918152 T DK 00918152T DK 00918152 T DK00918152 T DK 00918152T DK 1163271 T3 DK1163271 T3 DK 1163271T3
- Authority
- DK
- Denmark
- Prior art keywords
- recombinant
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12529999P | 1999-03-19 | 1999-03-19 | |
PCT/US2000/007349 WO2000056771A1 (en) | 1999-03-19 | 2000-03-17 | Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1163271T3 true DK1163271T3 (da) | 2008-11-10 |
Family
ID=22419067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00918152T DK1163271T3 (da) | 1999-03-19 | 2000-03-17 | Rekombinant IL-18 antistoffer og deres anvendelse |
Country Status (28)
Country | Link |
---|---|
US (2) | US6706487B1 (da) |
EP (2) | EP1961768A1 (da) |
JP (1) | JP2002542769A (da) |
KR (1) | KR100697120B1 (da) |
CN (1) | CN1246335C (da) |
AR (1) | AR022952A1 (da) |
AT (1) | ATE402191T1 (da) |
AU (1) | AU764622B2 (da) |
BR (1) | BR0008688A (da) |
CA (1) | CA2368965C (da) |
CO (1) | CO5470287A1 (da) |
CY (1) | CY1108387T1 (da) |
CZ (1) | CZ303704B6 (da) |
DE (1) | DE60039589D1 (da) |
DK (1) | DK1163271T3 (da) |
ES (1) | ES2308974T3 (da) |
HK (1) | HK1043798B (da) |
HU (1) | HU228931B1 (da) |
IL (1) | IL144995A0 (da) |
MY (1) | MY124219A (da) |
NO (1) | NO330391B1 (da) |
NZ (1) | NZ513699A (da) |
PL (1) | PL202396B1 (da) |
PT (1) | PT1163271E (da) |
SI (1) | SI1163271T1 (da) |
TR (3) | TR200102733T2 (da) |
WO (1) | WO2000056771A1 (da) |
ZA (1) | ZA200107639B (da) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852266A (en) * | 1993-07-14 | 1998-12-22 | Hitachi, Ltd. | Vacuum circuit breaker as well as vacuum valve and electric contact used in same |
US7704944B2 (en) | 1997-08-14 | 2010-04-27 | Yeda Research And Development Company Ltd. | Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis |
IL121860A0 (en) | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
US7220717B2 (en) | 1997-08-14 | 2007-05-22 | Yeda Research And Development Company Ltd. | Interleukin-18 binding proteins, their preparation and use |
CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
AR022952A1 (es) * | 1999-03-19 | 2002-09-04 | Smithkline Beecham Corp | ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL |
US7229619B1 (en) | 2000-11-28 | 2007-06-12 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
ES2349348T3 (es) * | 2000-01-27 | 2010-12-30 | Medimmune, Llc | Anticuerpos neutralizantes de rsv de ultra alta afinidad. |
TW201305214A (zh) * | 2000-02-10 | 2013-02-01 | Abbott Gmbh & Co Kg | 與人類間白素-18結合之抗體,及其製法及用途 |
KR20020086540A (ko) * | 2000-02-21 | 2002-11-18 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | Il-18 저해물질의 용도 |
WO2002032374A2 (en) * | 2000-10-18 | 2002-04-25 | Immunex Corporation | Methods for treating il-18 mediated disorders |
US7179900B2 (en) | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
US20040018195A1 (en) * | 2002-03-26 | 2004-01-29 | Griswold Don Edgar | Diabetes-related immunoglobulin derived proteins, compositions, methods and uses |
US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
AU2002343870A1 (en) | 2002-11-07 | 2004-06-07 | Kumamoto Technology And Industry Foundation | Transgenic mammal carrying ganp and utilization thereof |
WO2004097019A1 (ja) | 2003-04-30 | 2004-11-11 | Japan Science And Technology Agency | ヒト抗ヒトインターロイキン-18抗体およびその断片、並びにそれらの利用方法 |
US20050100965A1 (en) * | 2003-11-12 | 2005-05-12 | Tariq Ghayur | IL-18 binding proteins |
AU2011224023C1 (en) * | 2003-11-12 | 2013-08-29 | Abbvie Inc. | IL-18 binding proteins |
US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
US7141382B1 (en) | 2004-10-12 | 2006-11-28 | Parikh Chirag R | Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality |
JP5006330B2 (ja) | 2005-10-21 | 2012-08-22 | ノバルティス アーゲー | Il13に対するヒト抗体および治療的使用 |
GB0610438D0 (en) * | 2006-05-25 | 2006-07-05 | Glaxo Group Ltd | Immunoglobulins |
MY157173A (en) * | 2006-05-25 | 2016-05-13 | Glaxo Group Ltd | Modified humanised anti-interleukin-18 |
EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
US9403902B2 (en) | 2007-10-05 | 2016-08-02 | Ac Immune S.A. | Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody |
KR20100115340A (ko) * | 2007-10-19 | 2010-10-27 | 이무나스 파마 가부시키가이샤 | Aβ 올리고머에 특이적으로 결합하는 항체 및 그의 이용 |
US20100291071A1 (en) * | 2008-08-01 | 2010-11-18 | Immunas Pharma, Inc. | Antibody Specific Binding to A-Beta Oligomer and the Use |
CN102936287B (zh) * | 2008-02-08 | 2015-09-09 | 伊缪纳斯制药株式会社 | 能够特异性结合Aβ寡聚体的抗体及其应用 |
US20110189093A1 (en) * | 2008-04-14 | 2011-08-04 | Proscan Rx Pharma | Prostate specific membrane antigen antibodies and antigen binding fragments |
US9085614B2 (en) | 2008-08-01 | 2015-07-21 | Immunas Pharma, Inc. | Antibodies that specifically bind to Aβ oligomers and uses thereof |
JP2012500242A (ja) * | 2008-08-18 | 2012-01-05 | グラクソ グループ リミテッド | Il−18アンタゴニストを用いる自己免疫疾患の治療 |
WO2010040736A2 (en) * | 2008-10-07 | 2010-04-15 | Ablynx Nv | Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling |
US8168165B2 (en) * | 2008-12-23 | 2012-05-01 | Abbott Laboratories | Alkylated interleukin-18 compositions |
JP5812418B2 (ja) | 2009-04-17 | 2015-11-11 | イムナス・ファーマ株式会社 | Aβオリゴマーに特異的に結合する抗体およびその利用 |
EP2377583A1 (en) * | 2009-06-30 | 2011-10-19 | Gosen Co., Ltd. | Racket string, method for manufacturing same, and racket strung with same |
DK2462162T3 (da) | 2009-08-06 | 2017-01-16 | Immunas Pharma Inc | Antistoffer som specifikt binder til A-beta-oligomerer og anvendelse deraf |
ES2624835T3 (es) | 2009-08-06 | 2017-07-17 | Immunas Pharma, Inc. | Anticuerpos que se unen específicamente a los oligómeros A beta y uso de los mismos |
MX2012002605A (es) | 2009-08-29 | 2012-04-02 | Abbott Lab | Proteinas terapeutico de union a dll4. |
US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
WO2011098424A2 (en) * | 2010-02-09 | 2011-08-18 | Glaxo Group Limited | Treatment of a metabolic disorder |
EP2538965B1 (en) * | 2010-02-25 | 2017-04-12 | Schepens Eye Research Institute | Therapeutic compositions for the treatment of dry eye disease |
BR112012021941A2 (pt) * | 2010-03-02 | 2022-02-01 | Abbvie Inc | Proteínas terapêuticas de ligação a dll4 |
US20130109107A1 (en) * | 2010-05-25 | 2013-05-02 | The Regents Of The University Of Colorado | Diagnosis and treatment of autoimmune disease |
JP6081356B2 (ja) | 2010-07-30 | 2017-02-15 | エーシー イミューン エス.エー. | 安全で機能的なヒト化抗βアミロイド抗体 |
MX2013007067A (es) | 2010-12-20 | 2013-11-01 | Medimmune Ltd | Anticuerpos anti-il-18 y sus usos. |
JOP20200308A1 (ar) | 2012-09-07 | 2017-06-16 | Novartis Ag | جزيئات إرتباط il-18 |
US10570199B2 (en) | 2012-11-21 | 2020-02-25 | Km Biologics Co., Ltd. | Human antibody against IL-18 |
SG11201706879UA (en) * | 2015-03-05 | 2017-09-28 | Ab2 Bio Sa | Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases |
JP2023530489A (ja) * | 2020-06-18 | 2023-07-18 | ネクストキュア インコーポレイテッド | Flrt3媒介性シグナル伝達を調節するための組成物及び方法 |
EP4371573A1 (en) | 2021-07-13 | 2024-05-22 | National University Corporation Tokai National Higher Education and Research System | Medicinal composition for treating inflammatory bowel disease |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU22545A1 (es) * | 1994-11-18 | 1999-03-31 | Centro Inmunologia Molecular | Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico |
EP0307434B2 (en) | 1987-03-18 | 1998-07-29 | Scotgen Biopharmaceuticals, Inc. | Altered antibodies |
US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
ES2145004T3 (es) | 1991-08-21 | 2000-07-01 | Novartis Ag | Derivados de anticuerpos. |
GB9125979D0 (en) * | 1991-12-06 | 1992-02-05 | Wellcome Found | Antibody |
TW581771B (en) | 1994-11-15 | 2004-04-01 | Hayashibara Biochem Lab | Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide |
IL121860A0 (en) | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
FR2767697B1 (fr) | 1997-09-01 | 2000-05-05 | Boots Co Plc | Composition dermatologique permettant d'eviter l'apparition de symptomes d'hypersensibilite et d'intolerance cutanee |
CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
AR022952A1 (es) * | 1999-03-19 | 2002-09-04 | Smithkline Beecham Corp | ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL |
-
2000
- 2000-03-16 AR ARP000101168A patent/AR022952A1/es active IP Right Grant
- 2000-03-17 NZ NZ513699A patent/NZ513699A/xx not_active IP Right Cessation
- 2000-03-17 DE DE60039589T patent/DE60039589D1/de not_active Expired - Lifetime
- 2000-03-17 CO CO00019489A patent/CO5470287A1/es active IP Right Grant
- 2000-03-17 SI SI200031002T patent/SI1163271T1/sl unknown
- 2000-03-17 AU AU39016/00A patent/AU764622B2/en not_active Expired
- 2000-03-17 PL PL350460A patent/PL202396B1/pl unknown
- 2000-03-17 EP EP08157217A patent/EP1961768A1/en not_active Withdrawn
- 2000-03-17 PT PT00918152T patent/PT1163271E/pt unknown
- 2000-03-17 MY MYPI20001044A patent/MY124219A/en unknown
- 2000-03-17 TR TR2001/02733T patent/TR200102733T2/xx unknown
- 2000-03-17 EP EP00918152A patent/EP1163271B1/en not_active Expired - Lifetime
- 2000-03-17 DK DK00918152T patent/DK1163271T3/da active
- 2000-03-17 CZ CZ20013362A patent/CZ303704B6/cs not_active IP Right Cessation
- 2000-03-17 ES ES00918152T patent/ES2308974T3/es not_active Expired - Lifetime
- 2000-03-17 BR BR0008688-6A patent/BR0008688A/pt not_active Application Discontinuation
- 2000-03-17 JP JP2000606631A patent/JP2002542769A/ja active Pending
- 2000-03-17 CN CNB008077703A patent/CN1246335C/zh not_active Expired - Lifetime
- 2000-03-17 TR TR2002/02254T patent/TR200202254T2/xx unknown
- 2000-03-17 CA CA2368965A patent/CA2368965C/en not_active Expired - Lifetime
- 2000-03-17 IL IL14499500A patent/IL144995A0/xx not_active IP Right Cessation
- 2000-03-17 TR TR2002/02253T patent/TR200202253T2/xx unknown
- 2000-03-17 AT AT00918152T patent/ATE402191T1/de active
- 2000-03-17 KR KR1020017011872A patent/KR100697120B1/ko active IP Right Grant
- 2000-03-17 HU HU0200502A patent/HU228931B1/hu unknown
- 2000-03-17 WO PCT/US2000/007349 patent/WO2000056771A1/en active IP Right Grant
- 2000-03-17 US US09/914,695 patent/US6706487B1/en not_active Expired - Lifetime
-
2001
- 2001-09-17 ZA ZA200107639A patent/ZA200107639B/en unknown
- 2001-09-18 NO NO20014524A patent/NO330391B1/no not_active IP Right Cessation
-
2002
- 2002-05-21 HK HK02103813.7A patent/HK1043798B/zh not_active IP Right Cessation
-
2004
- 2004-01-22 US US10/762,629 patent/US20040141964A1/en not_active Abandoned
-
2008
- 2008-09-30 CY CY20081101085T patent/CY1108387T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1163271T3 (da) | Rekombinant IL-18 antistoffer og deres anvendelse | |
NO20014560D0 (no) | Quinasoliner og terapautisk anvendelse derav | |
NO20041225L (no) | Rekombinant anti-osteopontinantistoff og anvendelse derav | |
DK1352063T3 (da) | Receptor-nucleinsyrer og receptor-polypeptider | |
NO20021449L (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse | |
DK1390389T3 (da) | Cripto-blokerende antistoffer og anvendelser deraf | |
DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
IS6411A (is) | Kaspasa tálmar og notkun þeirra | |
DE60124863D1 (de) | Gegen menschliche interleukin-1-beta gerichtete rekombinante antikörper | |
DK1414471T3 (da) | Terapeutiske midler omfattende pro-apoptotiske proteiner | |
EE04027B1 (et) | Puhverseadis | |
NO20044192L (no) | 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater | |
NO20034405D0 (no) | Anti-ostepontin-antistoff og anvendelse derav | |
NO20001323D0 (no) | Dipeptid-apoptose inhibitorer og deres anvendelse | |
DK1328475T3 (da) | Zeolitter og deres anvendelse | |
DK1141308T3 (da) | Gruppe B streptococcus proteiner og deres anvendelse | |
DK1276762T3 (da) | Rekombinante porphyromonas gingivalis-proteiner og trunkeringer | |
NO20013085D0 (no) | Fosfororganiske forbindelser og deres anvendelse | |
PT1178981E (pt) | 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos | |
NO20030547D0 (no) | Azabicykliske derivater og deres terapeutiske anvendelse | |
FR2791348B1 (fr) | POLYPEPTIDE Npt2B | |
NO20020919D0 (no) | Irenprotein, dets fremstilling og anvendelse | |
NO20023015L (no) | Humant heparanasebeslektet polypeptid og nukleinsyre | |
DE60219418D1 (de) | Silanylphenole und -naphthole | |
NO20015906L (no) | Spleisosomprotein og dets anvendelse |